Abstract
Adrenal incidentalomas are detected more frequently with high-resolution imaging modalities. It is difficult to distinguish between benign and malignant lesions despite the so-called histologic Weiss criteria, imaging features, and molecular studies. We here present a 52 yr-old man who was found to have an adrenal incidentaloma during an annual check-up at his urologist. An 8 cm large adrenal lesion was detected on ultrasound, computed tomography, and magnetic resonance imaging with imaging features suggestive of malignancy. The lesion was hormonally inactive. A left-sided adrenalectomy was performed and histologic grading revealed a Weiss score of 2, suggesting a benign tumor. However, on further follow-up, the patient developed a local recurrence and pulmonary metastases diagnosed 6 yr after initial presentation. After repeat surgery in the left adrenal bed adrenocortical tumor tissue had a Weiss score of 8, clearly suggesting histologic malignancy. The patient received adjuvant mitotane therapy. Under this therapy, he developed a right-sided adrenal mass (contralateral from the primary tumor) of 2 cm size which disappeared during the following 9 months, whereas the pulmonary metastases remained unchanged, suggesting tumor clones with a variable response to treatment or spontaneous apoptosis. This case suggests that adrenal inciden-talomas larger than 6 cm with imaging features such as intratumoral necrosis suggestive of malignancy, should be managed as potential cancers independent of the so-called Weiss criteria. In such patients, close follow-up examinations including high-resolution imaging (preferably 3 monthly) are needed and should be carried out by a physician familiar/specialized in endocrine oncology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Russi S, Blumenthal HT, Gray SH. Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Int Med 1945, 76: 284–96.
Hedeland H, Ostberg G, Hokfelt B. On the prevalence of adrenolcortical adenomas in an autopsy material in relation to hypertension and diabetes. Act Med Scand 1968, 194: 211–4.
Kloos RT, Gross MD, Francis IR, et al. Incidentally discovered adrenal masses. End Rev 1995, 16: 460–84.
National Cancer Institute, Biometrics branch. In: Cutler SJ, Young JL eds. Third national cancer survey: incidence data. National Cancer Institute Monograph. Washington: Government Printing Office. 1975, 41: 75–787.
Wooten MD, King DK. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993, 72: 3145–55.
Weiss LM. Comparative histologic study of 43 metastasiz-ing and nonmetastasizing adrenocortical tumors. Am J Surg Path 1984, 8: 163–9.
Giquel C, Bertagna X, Gaston V, et al. Molecular marker and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Canc Res 2001, 61: 6762–7.
Koch CA, Pacak K, Chrousos GP. The molecular patho-genesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 2002, 87: 5367–84.
Abraham J, Bakke S, Rutt A, et al. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Cancer 2002, 94: 2333–43.
Korobkin M, Brodeur FJ, Francis IR, et al. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 1996, 200: 737–42.
National Institutes of Health. State-of-the-science-conference-statement. Managment of the Clinically Inapparent Adrenal Mass (“Incidentaloma”). Final statement 8/2002. http://consensus.nih.gov.
Kopf D, Goretzki PE, Lehnert H. Clinical management of malignant adrenal tumors. J Canc Res Clin Oncol 2001, 127: 143–55.
Terzolo M, Boccuzzi A, Bovio S, Cappia S, et al. Immunohis-tochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors. Urology 2001, 57: 176–82.
Dackiw A P, Lee JE, Gagel RF, Evans DB. Adrenal cortical carcinoma. World J Surg 2001, 25: 914–26.
Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of endocrinology. J Clin Endocrinol Metab 2000, 85: 637–44.
Barnett CC Jr, Varma DG, El-Naggar AK, et al. Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 2000, 128: 973–82.
Tang CK, Gray GF. Adrenocortical neoplasms. Prognosis and morphology. Urology 1977, 5: 691–5.
Falke THM, te Strake L, Shaff MJ, et al. MR imaging of the adrenals: correlation with computed tomography. J Comput Assist Tomogr 1986, 10: 242–53.
Bernardino ME. Managment of the asymptomatic patient with unilateral adrenal mass. Radiology 1988, 166: 121–3.
Davis PL, Hricak H, Bradley WG Jr. Magnetic resonance imaging of the adrenal glands. Radiol Clin North Am 1984, 22: 891–5.
Van Erkel AR, van Gils, APG, Lequin M, et al. CT and MR distinction of adenomas and nonadenomas of the adrenal glands. J Comput Assist Tomogr 1994, 18: 432–8.
McLoughlin RF, Bilbey JH. Tumors of the adrenal gland: findings on CT and MR imaging. Am J Roentgenol 1994, 163: 1413–8.
Reining JW, Doppman JL, Dwyer AJ, et al. MRI of indeterminate adrenal masses. AJR 1986, 147: 493–6.
Khafagi FA, Gross MD, Shapiro B, et al. Clinical significance of the large adrenal mass. Br J Surg 1991, 78: 828–33.
Siren JE, Haapiainen RK, Huikuri KT, et al. Incidentalomas of the adrenal gland: 36 operated patients and review of literature 1993, 17: 634–9.
Hussein S, Belldegrun A, Seltzer SE, et al. Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. AJR Am J Roentgenol 1985, 144: 61–5.
Paivansalo M, Lahde S, Merikanto J, et al. Computed tomography in primary and secondary adrenal tumours. Acta Radiol 1988, 29: 519–22.
Dominguez-Gadea L, Diez L, Bas C, et al. Differntial diagnosis of solid adrenal masses using adrenocortical szintigraphy. Clin Radiol 1994, 49: 796–9.
Gross MD, Shapiro B, Francis IR, et al. Scintigraphic evaluation of clinically silent adrenal masses, J Nucl Med 1994, 35: 1145–52.
Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991, 179: 415–8.
Gross MD, Shapiro B, Francis IR, et al. Incidentally discoverd bilateral adrenal masses. Eur J Nucl Med 1995, 22: 315–21.
Lucon AM, Pereira MA, Mendonca BB, et al. Adrenocortical tumors: results of treatment and study of the Weiss score as a prognostic factor. Rev Hosp Clin Fac Med Sao Paulo 2002, 57: 251–6.
Terzolo M, Ali A, Osella G, Mazza E. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemon-tese Incidentalomi Surrenalici. Arch Surg 1997, 132: 914–9.
Stojadinovic A, Ghossein RA, Hoos A, et al. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 2002, 20: 941–50.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pohlink, C., Tannapfel, A., Eichfeld, U. et al. Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?. J Endocrinol Invest 27, 565–569 (2004). https://doi.org/10.1007/BF03347480
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347480